Further comment from the AUA on new PSA screening guidance

The American Urological Association (AUA) sent the following additional message to its members with the past 90 minutes: … READ MORE …

Follow-up on the new AUA guidelines on screening for risk of prostate cancer

One of the things that is most interesting about the new guidelines issued by the AUA last week (see here for original announcement) is that they seem to be gaining reasonably widespread approval — probably because they are actually (and finally) based on actual evidence as opposed to raw opinion. … READ MORE …

ACP issues new guidance about PSA testing to primary care physicians

The Clinical Guidelines Committee of the American College of Physicians (ACP) — one of the most influential primary care medical societies in the USA — has just issued a new set of guidelines on screening for prostate cancer. Many prostate cancer patients are likely to be deeply disturbed by these guidelines. … READ MORE …

The scientific basis for PSA monitoring after first-line treatment for localized prostate cancer

A new article in the Canadian Medical Association Journal has reported on a careful analysis of the published literature underlying current guidelines on the use of repetitive PSA testing to monitor risk for progression in men receiving first-line treatment for localized prostate cancer. … READ MORE …

The new NCCN patient guidelines — a great improvement over last time

We have now had the chance to look carefully through the new, patient-specific guidelines on prostate cancer issued by the National Comprehensive Cancer Network (NCCN) just before the Holidays. They are not perfect, but they are certainly a vast improvement over the NCCN’s first attempt. … READ MORE …

NCCN issues completely revised edition of prostate cancer patient guidelines

The “New” Prostate Cancer InfoLink is pleased to see that — here in the USA — the National Comprehensive Cancer Network (NCCN) has just issued a fully revised, new edition of the NCCN Guidelines for Patients™ for Prostate Cancer (Version 1.2011). … READ MORE …

Bone mineral density and other risk factors for fractures in men on ADT

Clinical guidelines issued by the National Comprehensive Cancer Network recommend that prostate cancer patients being treated with androgen deprivation therapy (ADT) — either alone or in combination with radiation therapy — should be screened for osteoporosis and treatment to prevent deterioration of bone health associated with a decline in bone mineral density. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,142 other followers